NSEShareholders meeting29 Sept 2026 · 29 Sept 2026, 03:37 pm

Shareholders meeting

SMS Pharmaceuticals Limited · SMSPHARMA

✦ AI SummaryResults

SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026. The 38th Annual General Meeting of the Company was held through video conference in compliance with circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI) and other applicable provisions of the Companies Act, 2013.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026

Attachments (1)

📄

SMSPHARMA_29092026153724_Outcome.pdf

pdf

Download →
View document text
Date: 29th September, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, Bombay Stock Exchange Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Sub: Summary of Proceedings of the 38th Annual General Meeting of the Company- Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 We wish to inform you that the 38th Annual General Meeting (“AGM”) of the Members of the Company was held today, i.e. Tuesday, 29th September, 2026, through video conference/ other audio-visual means in compliance with circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI) and other applicable provisions of the Companies Act, 2013. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III thereto, please find enclosed the summary of proceedings of the AGM. This disclosure will also be hosted on the Company's website www.smspharma.com We request you to kindly take the same on record. Thanking you, Yours faithfully, For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary Encl : a/a SUMMARY OF PROCEEDINGS OF THE 38TH ANNUAL GENERAL MEETING OF SMS PHARMACEUTICALS LIMITED The 38th Annual General Meeting (“AGM”) of the Members of SMS Pharmaceuticals Limited (“Company”) was held today, i.e. Tuesday, 29th September, 2026 at 10:30 a.m. (IST) through video conference (“VC”) / other audio visual means (“OAVM”) in compliance with the provisions of the Companies Act, 2013 read with rules made thereunder, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India, from time to time, in this regard. Mr. Thirumalesh Tumma, Company Secretary & Compliance Officer of the Company welcomed the Members to the Meeting and briefed them on details relating to their participation at the Meeting through VC/OAVM. Mr. Ramesh Babu Potluri, Chairman and Managing Director of the Company, chaired the Meeting. The Chairman declared that as the requisite quorum being present, the meeting was called to order. As the Members are not required to physically present, and in line with the circulars issued by the Ministry of Corporate Affairs and SEBI, the provision for appointing proxies was not applicable. Following Directors of the Company attended the Meeting through video conference: Sl. No. Name of the Person Designation Mode of attending the Meeting 1 Mr. Ramesh Babu Chairman & Managing Physically present at the registered Potluri Director office and participated through VC 2 Mr. Shravan Kudaravalli Independent Director & Physically present at the registered Chairman of Audit Committee office and participated through VC 3 Mr. Sarvepalli Srinivas Independent Director Participated through VC from Noida 4 Dr. Suresh Kumar Independent Director Participated through VC from Gangavarapu Hyderabad 5 Mrs. Shanti Sree Bolleni Independent Director and Participated through VC from Chairperson of Nomination Hyderabad and Remuneration Committee 6 Mr. Vamsi Krishna Executive Director Physically present at the registered Potluri office and participated through VC 7 Dr. Sunkara Venkata Non-Executive Director and Physically present at the registered Satya Shiva Prasad Chairman of Stakeholder office and participated through VC Relationship Committee 8 Mr. Trilok Potluri Non-Executive Director Physically present at the registered office and participated through VC 9 Mr. Lakshmi Narayana Chief Financial Officer Physically present at the registered Tammineedi office and participated through VC 10 Mr. Thirumalesh Company Secretary Physically present at the registered Tumma office and participated through VC Statutory Auditors and Scrutinizer Sl. No. Name of the Person Particulars Mode of attending the Meeting 1 Mr. V. Nagendra Rao Statutory Auditor M/s. Participated through VC from Suryanarayana & Suresh Hyderabad Chartered Accountants 2 Mr. A. Venkateswara Internal Auditor M/s. Physically present at the Rao Adusumilli and Associates registered office and participated through VC 3 Mr. C. Sudhir Babu M/s. CSB Associates, Company Physically present at the Secretaries, Scrutinizer registered office and participated through VC It was informed the Members that electronic copy of the Annual Report for FY 2025-26 and Notice convening the 38th AGM were sent to Members by e-mail on their registered e-mail id. With the permission of the members, the Notice of the 38th Annual General Meeting was taken as read. The Chairman expressed his views with respect to the Industry scenario, long term growth, outlook, performance of the Company, challenges, opportunities going forward and other related matters. In pursuance of the relevant provisions of Companies Act 2013 read with the SEBI (LODR) Regulations, 2015 as amended from time to time, the Company has provided the E-voting facility by Central Depository Services (India) Limited (CDSL) to the Shareholders to cast their vote as mentioned in the Notice of the AGM where the e-voting was kept open from 25th September, 2026 (9.00 a.m.) to 28th September, 2026 (5.00 p.m.). Further the remote e-voting facility was also made available during the AGM for the benefit of Members who were present during the Meeting and had not cast their votes earlier through remote e- voting. The following items of business, as per the Notice convening the 38th AGM of the Company were transacted at the meeting. Item No. Agenda Item Type of resolution Ordinary/ Special Ordinary Business: 1. Adoption of Audited Standalone and Consolidated Financial Ordinary Statements of the Company for the Financial Year ended 31st March, 2026, and the reports of the Board of Directors and Auditors thereon. 2. Declaration of dividend on Equity shares for the financial year 2025- Ordinary 2026 3. Re-appointment of Dr. Sunkara Venkata Satya Shiva Prasad (DIN: Ordinary 10404277) who retires by rotation, and being eligible, offers himself for re-appointment Special Business: 4. Approval of material related party transaction(s) with VKT Pharma Ordinary Private Limited 5. Approval for remuneration payable to the Cost Auditors for the Ordinary Financial Year 2026-27 6. Approval for Re-appointment of Mr. Ramesh Babu Potluri (DIN: Special 00166381) as Chairman and Managing Director of the Company and fixation of remuneration 7. Approval to provide loan to SMS Peptides Private Limited, Special Subsidiary Company The Chairman then invited the Members to express their views, ask questions and seek clarifications on the operational and financial performance of the Company on the resolutions set out in the Notice. The Members were given an opportunity to speak in the order in which they had registered their names. After giving sufficient time to all Members who wished to speak, the Chairman along with Executive Directors appropriately responded to the queries raised by them. The Chairman informed the Members that Mr. C. Sudhir Babu, Practicing Company Secretary (Membership No; FCS 7666), Proprietor of M/s CSB Associates, Company Secretaries, was the Scrutinizer appointed by the Board to scrutinize the e-voting process during the meeting and through remote e- voting, in a fair and transparent manner. The Chairman authorized Mr. Thirumalesh Tumma, Company Secretary to accept and countersign the Scrutinizer’s Report and declare the consolidated e-voting results on receipt of the scrutinizer’s report. He informed the members that the combined results of the remote e-voting as well as e-voting during the AGM would be announced within two working days form the conclusion of the Meeting and the results along with the Scrutinizer’s report would be intimated to the S [Showing first 8,000 characters — download PDF for full document]